Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
In line with my previously stated expectations about big pharma continuing to do takeovers of existing established diagnostics companies. I have just seen the announcement about the BBI takeover by Novo……Wonder when others (NCYT, GDR, ABDX, ODX, etc) could follow….
by whom?
Another offer by who?
Good luck to all on this board with your impending takeover .
I’m not crossramping 28jazcar but as you mentioned NCYT which I am invested in and have been for the last 15 months I have seen many similarities and agree with your sentiments on small to mid cap diagnostic companies been snapped up by the big boys .
Yep, I don’t think it was a coincidence Antha......
One of my investing methods is to look out for such signs that are outside of the normal pattern of trading.....
I was planning on increasing my IDH holding today having seen those delayed 13th May trades over the weekend but alas the RNS has put paid to that.....anyway it’s still been a nice earner of 70% profit for a 6 month hold.
Best of luck with how you re-invest your profits. Personally I am taking a look at EVG which has some great IP and is cashed up but seems to have been forgotten by the market for the time being.
28ja, those mega buys and the timing would suggest to me there was a bit of insider trading going on, too coincidental.
IDH was always a well run company with great assets but not that good for short term traders (sorry draft), my strategy was to hold long term with maybe a T/O at some point, honestly didn't think it would happen so quickly.
Best not to sell just in case a bidding war starts, well done all.
Indeed.....Certainly no harm in waiting for it to play out.
I would not be surprised by a higher offer and it go contested.
Diagnostics company buyouts - new trend ?
The news here this morning has come sooner than I had envisaged and allows me to bank a nice profit...... -;)
However I think there is a bigger picture story potentially going on here whereby the previous sleepy town of the diagnostics world has really been woken up for the future by the covid pandemic.
Going forwards I can foresee that many of the large pharma companies will be looking to enhance their diagnostics credentials / capabilities. One of the fast-track ways to do this is to look to buy-out small to medium size existing diagnostics companies who have good IP etc, just like what has happened here with IDH.
I really see this as a wake up call for other Companies in this space such as the likes of GDR, ODX, NCYT etc......
28jaczar01/ Antha - You two were spot on with your takeover comments.
I sold for a loss about 3 weeks ago.
Good call 28J!
Congrats to all holders!
Well there you go. Is everyone in bed or have they fainted in shock? :)
I believe there is an ongoing accumulation of IDH shares by a significant buyer which was first started back in late April (see my previous thread). They look to have been slowly picking up shares in this illiquid stock over the past several weeks to avoid causing a SP spike.
Today we can see 2 very large buys printed from close of play yesterday (13th May). One for 140,000 shares at 260p and the other for 175,000 shares at 263p which like was done back in late April was sneakily reported over on the Aquis exchange......these two trades total up to be more than 1% of the Company.
They could continue to accumulate more stock in the coming weeks and if so sometime down the line we can expect to get a TR1 to tell us who is this mystery large volume buyer.....
is anticipating better news in the finals in a month or so, but if their Covid test product is taken up then the effect on their fairly modest usual profit could be significant. It would only take that pointer to move the SP here pretty sharply upward because very small capitalisation. Could be interesting few months.
Yes certainly looking good, I think the new base is 250p.
Just noticed hidden over on the Aquis exchange by those cheeky MMs, there is another delayed trade on 28th April at 112.5K which also looks to me to be a buy.......this is very interesting accumulation by someone as added together they are 0.73% of the total shares issued.....
Interesting to see 3 delayed trades showing up from 28th April for a total 100K shares done within a 1/2 hour period.....
I suspect they are all buys from the same buyer considering the SP has risen since then and this amount of shares represents several weeks of trading normally......
Let’s see where we head in the coming weeks with further IDH news etc....
I wouldn't read too much in to that, think it would only get a rns if a substantial contract was awarded which I assume none as yet have.
As I said before IDS is a very long term hold, without news it will inevitably dip below 200p again, I will be buying more then.
I reduced my holding and now this and they did not RNS this
IDS
@IDSDiagnostics
We welcomed the French Minister of Public Accounts, Olivier Dussopt to IDS Pouilly-en-Auxois site yesterday, after being one of the 35 winning companies in the health sector to be selected by the government to receive investment and further our vital work.
....so not under the radar any longer.
Very small free float of shares with IDH so it won’t take much buying as this week progresses to keep the SP heading north to hit £3+
Actually, it rose to 230p before falling back to 190p late yesterday and then immediately going up again today, hopefully it's due to incoming news, Covid sales figures maybe.
Even with the sp rise the company is still well under valued considering their extensive IP portfolio and cash in the bank, near term it should be 300p plus.
Something fishy! It was up 23% on just one trade this morning!